EP0155009B1 - Medical tube - Google Patents
Medical tube Download PDFInfo
- Publication number
- EP0155009B1 EP0155009B1 EP85103028A EP85103028A EP0155009B1 EP 0155009 B1 EP0155009 B1 EP 0155009B1 EP 85103028 A EP85103028 A EP 85103028A EP 85103028 A EP85103028 A EP 85103028A EP 0155009 B1 EP0155009 B1 EP 0155009B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- probe
- distal end
- tube
- metal head
- closure cap
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000523 sample Substances 0.000 claims abstract description 88
- 229910052751 metal Inorganic materials 0.000 claims abstract description 35
- 239000002184 metal Substances 0.000 claims abstract description 35
- 108010010803 Gelatin Proteins 0.000 claims abstract description 22
- 229920000159 gelatin Polymers 0.000 claims abstract description 22
- 235000019322 gelatine Nutrition 0.000 claims abstract description 22
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 22
- 239000008273 gelatin Substances 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 17
- 210000004051 gastric juice Anatomy 0.000 claims abstract description 8
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims abstract 5
- 230000008719 thickening Effects 0.000 claims description 16
- 235000013305 food Nutrition 0.000 claims description 7
- 230000000968 intestinal effect Effects 0.000 claims description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 3
- 229920006318 anionic polymer Polymers 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 abstract description 6
- 238000000576 coating method Methods 0.000 abstract description 6
- 210000003128 head Anatomy 0.000 description 25
- 239000010410 layer Substances 0.000 description 11
- 239000011247 coating layer Substances 0.000 description 10
- 235000016709 nutrition Nutrition 0.000 description 9
- 230000035764 nutrition Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- 208000003443 Unconsciousness Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 210000003238 esophagus Anatomy 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229920003137 Eudragit® S polymer Polymers 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000008855 peristalsis Effects 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000002195 soluble material Substances 0.000 description 3
- 235000000053 special nutrition Nutrition 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 206010036590 Premature baby Diseases 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- 229940043351 ethyl-p-hydroxybenzoate Drugs 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 210000001630 jejunum Anatomy 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 238000011903 nutritional therapy Methods 0.000 description 2
- 235000016236 parenteral nutrition Nutrition 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920003136 Eudragit® L polymer Polymers 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 239000004063 acid-resistant material Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 210000004086 maxillary sinus Anatomy 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001107 psychogenic effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 235000019613 sensory perceptions of taste Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035923 taste sensation Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000021476 total parenteral nutrition Nutrition 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0003—Nasal or oral feeding-tubes, e.g. tube entering body through nose or mouth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0026—Parts, details or accessories for feeding-tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2200/00—General characteristics or adaptations
- A61J2200/60—General characteristics or adaptations biodegradable
Definitions
- the present invention relates to a medical probe, in particular for enteral nutrition, according to the features of the preamble of claim 1.
- Medical probes for enteral nutrition are already known.
- these probes consist of the actual probe tube, at the distal end of which a closure cap is arranged, and the proximal end of which there are connecting devices via which the probe with the nutritional pump and further feed devices (such as further tubes and the like) for food and the like. or is connected to the stylet, and a stylet.
- the stylet serves to temporarily stiffen the relatively soft probe tube. It facilitates the placement of the probe and is removed after the placement or placement of the probe.
- PVC, polyurethane or silicone is generally used as the material for the probe tube, while the sealing cap is made of polyethylene or silicone.
- Tube feeding has become particularly important in recent years.
- the indication for artificial nutrition is always given when a patient is not allowed to eat, cannot eat or does not want to eat.
- the respective nutritional therapy is tailored to the condition of the respective patient.
- This nutritional therapy is not only important in the postoperative or post-traumatic area, but also in diseases that are associated with a disturbance in the absorption or digestion of nutrients and as a complementary therapy for cancer patients.
- So special nutrition is carried out for oral diseases, e.g. Operations in the oral and maxillary sinuses, paralysis of the chewing muscles, with continued loss of consciousness, e.g. in traumatic brain injuries, in ventilated and relaxed patients, e.g. Tetanus patients, in patients with refusal to eat for a psychogenic cause, e.g.
- nasogastric nasoduodenal and nasojejunal special nutrition.
- probes with a sealing cap have previously been used as a guide bolus (e.g. made of mercury or water).
- a guide bolus e.g. made of mercury or water.
- placement of the feeding tubes requires intact gastroduodenal peristalsis. Occasionally, these probes can also be placed intraoperatively.
- the nasoduodenal and nasojejunal feeding tubes are used primarily in the field of conservative medicine for unconscious patients, long-term ventilation patients, relaxed patients and for premature babies.
- Probes are already known which have a balloon as the guide bolus which can be filled with a liquid, for example mercury or water, which is intended to facilitate the placement of the tube.
- a liquid for example mercury or water
- Such probes are known from DE-A 3 105 883, DE-A 2914609, DE-A 2 402 573, DE-A 2 524 030, DE-A 2 810 326, DE-A 2 721 548, the article by Rueff et al. in Kunststoff Medical Weekly (1968, pages 470-474) and the catalog of the company Hinsch (1977, pages 15-19).
- the balloon is glued to the probe with an agent that is soluble in the small intestine and can be removed by detaching after placement.
- the invention has for its object to develop the probe of the type mentioned in such a way that it can be easily moved by the peristaltic movement of the esophageal gastrointestinal tract after placement lies safely and does not disturb the digestive process.
- a cap enlarged in this way offers a better point of attack for the peristalsis of the esophagus, stomach and / or intestine, which is particularly important in the case of passive patients (eg, unconscious patients).
- Suitable materials that can be absorbed by the patient's body are pharmacologically acceptable solidifying substances, such as agar, alginic acids, starches, arabic gum, pectin PVP, methyl cellulose and gelatin, gelatin being preferred.
- Suitable as gelatin are all commercially available, usable for medical purposes gelatins, such as soft gelatin and hard gelatin, or gelatin masses, which, if appropriate, further additives suitable for medical purposes, such as plasticizers (such as sorbitol) glycerol, alkali metal salts (sodium salts) of ethyl p-hydroxybenzoate or propyl p-hydroxybenzoate, and water and the like. contain.
- plasticizers such as sorbitol
- alkali metal salts sodium salts of ethyl p-hydroxybenzoate or propyl p-hydroxybenzoate, and water and the like.
- Soft gelatin or a gelatin mass is preferably used which, in addition to gelatin, also contains sorbitol, glycerol, the sodium salt of ethyl p-hydroxybenzoate, the sodium salt of propyl p-hydroxybenzoate and water.
- This gelatin is broken down after placing the probe.
- the thickness of the thickening layer is not critical and the coating layer should, however, be so thick that the placement of the probe is improved to the desired extent, but on the other hand does not hinder the placement of the probe, i.e. should be such that the probe bolus offers a favorable point of attack for peristalsis. Suitable thicknesses are 3-6, in particular 4-5 mm with a probe diameter of approximately 2 mm. The jump in thickness between the thickening layer and the probe is of particular importance, since this jump ensures improved probe transport.
- the thickness jump (or the maximum wall thickness of the thickening) is advantageously in a range from 0.5-2, preferably 1-1.5 mm.
- the thickening layer is applied to a customary cap or stopper made of a suitable, medically compatible material, such as hard gelatin or plastic (e.g. made of polyolefin, in particular polyethylene, or silicone) arranged in the distal end of the probe tube.
- a suitable, medically compatible material such as hard gelatin or plastic (e.g. made of polyolefin, in particular polyethylene, or silicone) arranged in the distal end of the probe tube.
- a coat or a further coating layer made of acid-resistant material is applied on the thickening layer of the cap.
- This additional coating layer not only further enlarges and solidifies the closure cap or probe tip and thus further facilitates the placement of the probe tube, but in particular provides a probe for nasoduodenal and / or nasojejunal nutrition, which due to the enlargement of the closure cap or probe tip (- bolus) easily - even in passive patients - and unaffected by gastric acid passes through the stomach and can be safely placed in the duodenum or jejunum.
- a material for this further coating layer one is used which is resistant to gastric acid or gastric juice, but in intestinal juice, i.e. in the intestinal milieu, is soluble.
- Such materials are medically safe materials, such as anionic polymers made from methacrylic acid and methyl methacrylate, and mixtures thereof with other materials and with one another.
- Anionic polymers of methacrylic acid and methyl methacrylate such as Eudragit S, Eudragit L and mixtures thereof (manufactured by Röhm Pharma), in particular Eudragit S, are preferred.
- Shellack and cellulose acetate phthalate are also suitable as coating material.
- the thickness of the coating layer is not critical, but the coating layer should be so thick that the thickening layer is protected from the attack of the gastric juices and on the other hand not so thick that it dissolves too slowly and thus preventing any removal of the probe from the duodenum or jejunum. Suitable thicknesses are approximately 10-30 ⁇ m, in particular approximately 25 ⁇ m.
- the coating can be colorless, transparent, white or pigmented in a different color; it is preferably matched to the color of the probe tube.
- the closure cap advantageously has a metal head or metal plug in its bore, which is arranged at the distal end of the probe tube, or the closure cap can be designed as a metal head or metal plug.
- a metal head increases the weight of the probe and stiffens the distal end of the probe, thus considerably simplifying the placement or placement of the probe, particularly in the case of passive patients.
- Suitable materials for the metal head or the metal plug are suitable, suitable metals for medical purposes, such as e.g. Stainless steel, precious metals and the like Metal heads or plugs made of V4A and V2A steel are used in particular.
- the size of the metal head is not critical and should be in the usual size range for sealing caps or can be somewhat smaller, but should be large enough that the metal head can perform the desired function.
- the metal head suitably has approximately the same outer diameter as the probe, while its length is determined by the weight or the holder in the probe.
- the metal head can have any suitable shape. It is preferably inserted in the shape of a plug into the distal end of the probe tube by means of a neck.
- the thickening layer is then arranged over the sealing cap designed as a metal head or over the sealing cap comprising a metal head made of suitable, medically compatible material such as hard gelatin or plastic (e.g. polyolefin, such as polyethylene or silocon), over which the coating layer of gastric juice-resistant, in Intestinal juice soluble material, is applied.
- suitable, medically compatible material such as hard gelatin or plastic (e.g. polyolefin, such as polyethylene or silocon), over which the coating layer of gastric juice-resistant, in Intestinal juice soluble material, is applied.
- the probe tube itself consists of a conventional material suitable for probes, such as PVC, silicone or polyurethane, preferably of silicone or polyurethane.
- a stylet designed in the usual way is used to temporarily stiffen the relatively soft probe tube. If the metal head according to the invention is present at the distal end of the probe tube, the stylet opens into a depression or bore in the metal head or the neck part of this metal head in order to prevent the probe tube from kinking at the tip. This bore is preferably provided in the neck part of the metal head.
- the probe tube has openings in the usual way in the region of the distal end, which allow food to escape.
- the number of openings is not critical. However, there should be so many openings that proper food leakage is permitted. There are preferably two to four, in particular three, openings.
- marking lines are preferably provided in the usual way on the probe tube, which serve for orientation when the probe is placed.
- nasogastric probes are 75 cm long and have an inner diameter of 2-4 mm;
- Nasoduodenal or nasojejunal probes have a length of preferably 1.25 m, an inner diameter of 1.2-1.6 mm and an outer diameter of 2-2.4 mm.
- connection devices which are used once for attaching the stylet or later after placing the probe in the usual manner for receiving or connecting connecting lines or hoses, via which the probe with the nutritional pump or other supply lines for the food is attached, attached.
- connection devices can be present, for example, in the form of a connector part with a Luer connection, a plug connection or the like.
- a plug-in connection or a connector part with a Luer cone is preferably used, in particular a connector part with a Luer cone.
- the probe according to the invention is produced in the usual way.
- the metal head is preferably inserted into the distal end of the probe tube in a plug-like manner via a neck-shaped part of the metal piece.
- the distal end of the probe tube equipped with the metal head can be provided with the thickening layer by immersing the end of the distal probe tube provided with the metal head in a heated gelatin mass and then pulling it out in order to cover it with a further coating of gastric juice-resistant material coat what can be done in the usual way, if necessary by spraying.
- the immersion of the distal end in the heated gelatin mass is preferably done by oblique immersion, i.e. Immerse at an angle of less than 90 °.
- connection or connection device 3 for the stylet 6 or other supply or connection lines, which, as shown, can be in the form of a luer connection or can have any other suitable shape, e.g. can be in the form of a plug connection.
- connection device the corresponding connection or connection device 4 of the stylet 6 is inserted, which is preferably so-called to facilitate handling.
- Handle strips 5 carries.
- the metal head 7 is arranged in the probe tube 2 in the form of a plug.
- a thickening layer 8 made of a material that can be resorbed by the patient's body, preferably gelatin, on which a coating layer 9 made of an enteric, enteric material (preferably Eudragit S) is applied.
- This thickening layer 8 advantageously has the dimensions mentioned above.
- one or more openings 10 are provided in the probe tube for the food to exit.
- FIG. 2 illustrates an enlarged longitudinal section through the region of the distal end and the bolus of the probe according to the invention according to FIG. 1, the reference numbers corresponding to those used in FIG. 1.
- the probe tip or the probe bolus 1 with the metal head 7 which is placed on the distal end of the probe tube 2 and is inserted into the tube end in the form of a plug with the neck part 7a is clearly visible in the enlarged representation.
- the neck part 7a of the metal head 7 has a bore 11 for receiving the distal end of the stylet 6.
- This metal head can also have another suitable shape, e.g. it can be pear-shaped, or it can be essentially cylindrical.
- the thickening layer 8 is first applied to the distal end of the probe tube 2 and the metal head 7, and the coating layer 9 made of gastric juice-resistant, intestinal juice-soluble material is applied thereon.
- the openings 10 in the tube 2 are used for food leakage.
- the cross section shown in FIG. 3 along the line 11-11 according to FIG. 1 or 2 shows how the distal end of the probe tube 2 surrounds the neck part 7a of the metal head 7 and even of the thickening layer 8 and the coating layer 9 made of the enteric, enteric-soluble Material is surrounded.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Materials For Medical Uses (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Die vorliegende Erfindung betrifft eine medizinische Sonde, insbesondere für die enterale Ernährung, gemäß den Merkmalen des Oberbegriffs des Anspruchs 1.The present invention relates to a medical probe, in particular for enteral nutrition, according to the features of the preamble of claim 1.
Medizinische Sonden für die enterale Ernährung sind bereits bekannt. Im allgemeinen bestehen diese Sonden aus dem eigentlichen Sondenschlauch, an dessem distalen Ende eine Verschlußkappe angeordnet ist und dessem proximales Ende Anschlußeinrichtungen, über welche die Sonde mit der Ernährungspumpe und weiteren Zuführungseinrichtungen (wie weiteren Schläuchen u.dgl.) für die Nahrung u.dgl. bzw. mit dem Mandrin verbunden wird, aufweist, sowie einem Mandrin. Der Mandrin dient zur temporären Versteifung des relativ weichen Sondenschlauches. Er erleichtert das Plazieren der Sonde und wird nach dem Plazieren bzw. Legen der Sonde entfernt. Als Material für den Sondenschlauch wird im allgemeinen PVC, Polyurethan oder Silicon verwendet, während die Verschlußkappe aus Polyethylen oder Silicon besteht.Medical probes for enteral nutrition are already known. In general, these probes consist of the actual probe tube, at the distal end of which a closure cap is arranged, and the proximal end of which there are connecting devices via which the probe with the nutritional pump and further feed devices (such as further tubes and the like) for food and the like. or is connected to the stylet, and a stylet. The stylet serves to temporarily stiffen the relatively soft probe tube. It facilitates the placement of the probe and is removed after the placement or placement of the probe. PVC, polyurethane or silicone is generally used as the material for the probe tube, while the sealing cap is made of polyethylene or silicone.
Die Sondenernährung hat in den letzten Jahren insbesondere an Bedeutung gewonnen. Die Indikation zur künstlichen Ernährung ist immer dann gegeben, wenn ein Patient nicht essen darf, nicht essen kann oder nicht essen will. Die jeweilige Ernährungstherapie wird dabei auf den Zustand des jeweiligen Patienten abgestimmt. Diese Ernährungstherapie hat nicht nur ihre Bedeutung im postoperativen oder posttraumatischen Bereich, sondern auch bei Erkrankungen, die mit einer Störung der Aufnahme oder der Verdauung von Nährstoffen einhergehen sowie als ergänzende Therapie bei Krebspatienten. So wird Sonderernährung durchgeführt bei oralen Erkrankungen, z.B. Operationen im Mund- und Kieferhöhlenbereich, Lähmungen der Kaumuskulatur, bei anhaltender Bewußtlosigkeit, z.B. bei Schädel-Hirn-Traumen, bei beatmeten und relaxierten Patienten, z.B. Tetanuspatienten, bei Patienten mit Nahrungsverweigerung aus psychogener Ursache, z.B. bei Magersucht, bei Krebspatienten, die häufig Geschmacksmißempfindungen haben, sowie in der Pädiatrie. Sonderernährung ist, wie Untersuchungen ergeben haben, verglichen mit der totalen parenteralen Ernährung mit weniger und weniger schweren Komplikationen verbunden und darüber hinaus preisgünstiger als die parenterale Ernährung. Das bedeutet jedoch, daß die Sonderernährung gegenüber der parenteralen Ernährung vorteilhafter ist und ihr somit, bis auf wenige Ausnahmen, in der Therapie der Mangelernährung der Vorzug gegeben wird.Tube feeding has become particularly important in recent years. The indication for artificial nutrition is always given when a patient is not allowed to eat, cannot eat or does not want to eat. The respective nutritional therapy is tailored to the condition of the respective patient. This nutritional therapy is not only important in the postoperative or post-traumatic area, but also in diseases that are associated with a disturbance in the absorption or digestion of nutrients and as a complementary therapy for cancer patients. So special nutrition is carried out for oral diseases, e.g. Operations in the oral and maxillary sinuses, paralysis of the chewing muscles, with continued loss of consciousness, e.g. in traumatic brain injuries, in ventilated and relaxed patients, e.g. Tetanus patients, in patients with refusal to eat for a psychogenic cause, e.g. in anorexia, in cancer patients who often have taste sensations, and in pediatrics. Special studies have shown that compared to total parenteral nutrition, less and less serious complications are involved and, moreover, cheaper than parenteral nutrition. However, this means that special nutrition is more advantageous than parenteral nutrition and, with a few exceptions, it is therefore preferred in the treatment of malnutrition.
Im allgemeinen wird zwischen nasogastrischer, nasoduodenaler und nasojejunaler Sonderernährung unterschieden. Für die nasoduodenale und nasojejunale Ernährung wurden bisher Sonden mit einer Verschlußkappe als Führungsbolus (z. B. aus Quecksilber oder Wasser) eingesetzt. Die Plazierung der Ernährungssonden setzt jedoch eine intakte gastroduodenale Peristaltik voraus. Gelegentlich können diese Sonden auch intraoperativ plaziert werden. Die nasoduodenalen und nasojejunalen Ernährungssonden werden vor allem im Bereich der konservativen Medizin bei bewußtlosen Patienten, Dauerbeatmungspatienten, relaxierten Patienten und bei Frühgeborenen eingesetzt. Sie haben darüber hinaus im chirurgischen Bereich bei stark mangelernährten Patienten zur Operationsvorbereitung, als Alternative zur Operation und in der Nachbehandlung (z.B. Chemo-oder Strahlentherapie maligner Tumoren) unstreitbare Bedeutung. Insbesondere bei Verwendung zur Ernährung von bewußtlosen Patienten, krebskranken Patienten, Frühgeborenen und Kleinkindern, die selbst bei der Plazierung nicht aktiv mithelfen können, treten beim Plazieren der Sonden bei Verwendung der bisherigen Sonden erhebliche Schwierigkeiten und Probleme auf, so daß häufig die gezielte und erfolgreiche Ernährung dieser Patienten in Frage gestellt ist.In general, a distinction is made between nasogastric, nasoduodenal and nasojejunal special nutrition. For nasoduodenal and nasojejunal nutrition, probes with a sealing cap have previously been used as a guide bolus (e.g. made of mercury or water). However, placement of the feeding tubes requires intact gastroduodenal peristalsis. Occasionally, these probes can also be placed intraoperatively. The nasoduodenal and nasojejunal feeding tubes are used primarily in the field of conservative medicine for unconscious patients, long-term ventilation patients, relaxed patients and for premature babies. They are also of undisputed importance in the surgical field of severely malnourished patients for preparation for surgery, as an alternative to surgery and in post-treatment (e.g. chemotherapy or radiation therapy of malignant tumors). Especially when used for the nutrition of unconscious patients, cancer patients, premature babies and small children, who cannot actively help even with the placement, there are considerable difficulties and problems when placing the probes when using the previous probes, so that often the targeted and successful nutrition this patient is questioned.
Es sind bereits Sonden bekannt, die als Führungsbolus einen Ballon aufweisen, der mit einer Flüssigkeit, beispielsweise Quecksilber oder Wasser, gefüllt werden kann, wodurch die Plazierung des Schlauches erleichtert werden soll. Derartige Sonden sind aus der DE-A 3 105 883, DE-A 2914609, DE-A 2 402 573, DE-A 2 524 030, DE-A 2 810 326, DE-A 2 721 548, dem Artikel von Rueff et al. in Münchner Medizinischer Wochenschrift (1968, Seiten 470-474) und dem Katalog der Firma Rüsch (1977, Seiten 15-19) bekannt. In der erstgenannten Patentschrift ist der Ballon mit einem im Dünndarm löslichen Mittel an der Sonde angeklebt und kann nach dem Plazieren durch Ablösen entfernt werden.Probes are already known which have a balloon as the guide bolus which can be filled with a liquid, for example mercury or water, which is intended to facilitate the placement of the tube. Such probes are known from DE-A 3 105 883, DE-A 2914609, DE-A 2 402 573, DE-A 2 524 030, DE-A 2 810 326, DE-A 2 721 548, the article by Rueff et al. in Munich Medical Weekly (1968, pages 470-474) and the catalog of the company Rüsch (1977, pages 15-19). In the first-mentioned patent, the balloon is glued to the probe with an agent that is soluble in the small intestine and can be removed by detaching after placement.
Sämtliche bekannten Sonden, die einen Ballon aufweisen, besitzen den Nachteil, daß sie zunächst beim Setzen durch die Nase nur in einem beschränkten Umfang gefüllt werden können, also bereits das Plazieren in der Nase Schwierigkeiten macht.All known probes, which have a balloon, have the disadvantage that they can only be filled to a limited extent when they are first inserted through the nose, thus already placing them in the nose makes them difficult.
Beim weiteren Fortbewegen der Sonde durch die Speiseröhre wird dann der Ballon mit der Flüssigkeit gefüllt. Auch hier bestehen erhebliche Schwierigkeiten bei der Fortbewegung der Sonde durch die Speiseröhre, da die im Ballon enthaltene Flüssigkeit der peristaltischen Bewegung von Speiseröhre und Magen ausweicht, so daß auch hier ernsthafte Plazierungsprobleme beobachtet werden. Andererseits wurden bisher jedoch nur Sonden mit einer metallischen Verschlußkappe am distalen Ende eingesetzt, die nur unwesentlich dicker war als der Schlauch selbst, so daß hierdurch keine Plazierungshilfe gegeben ist.As the probe moves further through the esophagus, the balloon is then filled with the liquid. Here, too, there are considerable difficulties in moving the probe through the esophagus, since the liquid contained in the balloon evades the peristaltic movement of the esophagus and stomach, so that serious placement problems are also observed here. On the other hand, however, so far only probes with a metallic cap at the distal end have been used, which was only insignificantly thicker than the tube itself, so that this does not provide any placement aid.
Aus der DE-A 2 824 893 ist eine Sonde für die enterale Behandlung bekannt, die an ihrem Ende mit einem ablösbaren Bolus versehen ist. Eine derartige Anordnung ist nachteilig, da der nicht beschwerte SondenseAlauch häufig in den Magen des Patienten zurückrutscht, was grundsätzlich zu vermeiden ist.From DE-A 2 824 893 a probe for enteral treatment is known which is provided with a detachable bolus at its end. Such an arrangement is disadvantageous because the unweighted tube often slips back into the patient's stomach, which is to be avoided in principle.
Insofern liegt der Erfindung die Aufgabe zugrunde, die Sonde der eingangs erwähnten Art so fortzubilden, daß sie sich durch die peristaltische Bewegung des Speiseröhre-Magendarmkanals problemlos fortbewegen läßt, nach der Plazierung sicher liegt und nicht den Verdauungsvorgang stört.In this respect, the invention has for its object to develop the probe of the type mentioned in such a way that it can be easily moved by the peristaltic movement of the esophageal gastrointestinal tract after placement lies safely and does not disturb the digestive process.
Die Lösung dieser Aufgabe erfolgt durch die Merkmale des kennzeichnenden Teils des Anspruchs 1.This object is achieved by the features of the characterizing part of claim 1.
Eine so vergrößerte Verschlußkappe bietet einen besseren Angriffspunkt für die Peristaltik von Speiseröhre, Magen und/oder Darm, was insbesondere bei passiven Patienten (z. B. bewußtlosen Patienten) besonders wichtig ist.A cap enlarged in this way offers a better point of attack for the peristalsis of the esophagus, stomach and / or intestine, which is particularly important in the case of passive patients (eg, unconscious patients).
Als vom Körper des Patienten resorbierbare Materialien eignen sich pharmakologisch unbedenkliche erstarrende Substanzen, wie Agar, Alginsäuren, Stärken, Arabisch-Gummi, Pektin PVP, Methylcellulose und Gelatine, wobei Gelatine bevorzugt ist.Suitable materials that can be absorbed by the patient's body are pharmacologically acceptable solidifying substances, such as agar, alginic acids, starches, arabic gum, pectin PVP, methyl cellulose and gelatin, gelatin being preferred.
Als Gelatine geeignet sind alle handelsüblichen, für medizinische Zwecke brauchbaren Gelatinen, wie Weichgelatine und Hartgelatine, bzw. Gelatinemassen, die gegebenenfalls weitere, für medizinische Zwecke geeignete Zusätze, wie Weichmacher, (wie z.B. Sorbit) Glycerin, Alkalisalze (Natriumsalze) von p-Hydroxybenzoesäureethylester oder p-Hydroxybenzoesäurepropylester, sowie Wasser u.dgl. enthalten. Vorzugsweise wird Weichgelatine oder eine Gelatinemasse verwendet, die neben Gelatine noch Sorbit, Glycerin, das Natriumsalz von p-Hydroxybenzoesäureethylester, das Natriumsalz von p-Hydroxybenzoesäurepropylester und Wasser enthält, verwendet. Eine geeignete und bevorzugte Zusammensetzung der erfindungsgemäß verwendeten Gelatinemasse ist folgende:Suitable as gelatin are all commercially available, usable for medical purposes gelatins, such as soft gelatin and hard gelatin, or gelatin masses, which, if appropriate, further additives suitable for medical purposes, such as plasticizers (such as sorbitol) glycerol, alkali metal salts (sodium salts) of ethyl p-hydroxybenzoate or propyl p-hydroxybenzoate, and water and the like. contain. Soft gelatin or a gelatin mass is preferably used which, in addition to gelatin, also contains sorbitol, glycerol, the sodium salt of ethyl p-hydroxybenzoate, the sodium salt of propyl p-hydroxybenzoate and water. A suitable and preferred composition of the gelatin mass used according to the invention is as follows:
Diese Gelatine wird nach Plazieren der Sonde abgebaut.This gelatin is broken down after placing the probe.
Die Dicke der Verdickungsschicht ist nicht kritisch, und die Überzugsschicht sollte jedoch so dick sein, daß das Plazieren der Sonde im gewünschten Maße besser wird, andererseits jedoch die Plazierung der Sonde nicht behindert wird, d.h. sollte so sein, daß der Sondenbolus einen günstigen Angriffspunkt für die Peristaltik bietet. Geeignete Dicken sind 3-6, insbesondere 4-5 mm bei einem Sondendurchmesser von etwa 2 mm. Von besonderer Bedeutung ist der Dickensprung zwischen der Verdickungsschicht und der Sonde, da dieser Sprung einen verbesserten Sondentransport gewährleistet. Vorteilhafterweise liegt der Dickensprung (oder die maximale Wanddicke der Verdickung) in einem Bereich von 0,5-2, vorzugsweise 1-1,5 mm.The thickness of the thickening layer is not critical and the coating layer should, however, be so thick that the placement of the probe is improved to the desired extent, but on the other hand does not hinder the placement of the probe, i.e. should be such that the probe bolus offers a favorable point of attack for peristalsis. Suitable thicknesses are 3-6, in particular 4-5 mm with a probe diameter of approximately 2 mm. The jump in thickness between the thickening layer and the probe is of particular importance, since this jump ensures improved probe transport. The thickness jump (or the maximum wall thickness of the thickening) is advantageously in a range from 0.5-2, preferably 1-1.5 mm.
Die Verdickungsschicht ist auf einer im distalen Ende des Sondenschlauches angeordneten üblichen Kappe oder Stopfen aus geeignetem, medizinisch verträglichem Material, wie Hartgelatine oder Kunststoff (z. B. aus Polyolefin, insbesondere Polyethylen, oder Silicon) aufgebracht.The thickening layer is applied to a customary cap or stopper made of a suitable, medically compatible material, such as hard gelatin or plastic (e.g. made of polyolefin, in particular polyethylene, or silicone) arranged in the distal end of the probe tube.
Auf der Verdickungsschicht der Verschlußkappe ist eine Mantel- bzw. eine weitere Überzugsschicht aus säurefestem Material aufgebracht. Durch diese weitere Überzugsschicht wird nicht nur die Verschlußkappe bzw. Sondenspitze weiter vergrößert und verfestigt und damit die Plazierung des Sondenschlauches weiter erleichtert, sondern insbesondere für die nasoduodenale und/oder nasojejunale Ernährung eine Sonde bereitgestellt, die infolge der Vergrößerung der Verschlußkappe bzw. Sondenspitze (-bolus) leicht-auch bei passiven Patienten - und von der Magensäure unangegriffen den Magen passiert und sicher im Duodenum bzw. Jejunum plaziert werden kann. Als Material für diese weitere Überzugsschicht wird ein solches verwendet, das gegenüber der Magensäure bzw. dem Magensaft resistent ist, aber im Darmsaft, d.h. im Milieu des Darmes, löslich ist. Beispiele für solche Materialien sind medizinisch unbedenkliche Materialien, wie anionische Polymerisate aus Methacrylsäure und Methacrylsäuremethylester, sowie Gemische derselben mit anderen Materialien sowie miteinander. Bevorzugt sind anionische Polymerisate aus Methacrylsäure und Methacrylsäuremethylester, wie Eudragit S, Eudragit L und Gemische derselben (hergestellt von Röhm Pharma), insbesondere Eudragit S. Weiterhin geeignet sind Shellack und Celluloseacetatphthalat als Überzugsmaterial.On the thickening layer of the cap, a coat or a further coating layer made of acid-resistant material is applied. This additional coating layer not only further enlarges and solidifies the closure cap or probe tip and thus further facilitates the placement of the probe tube, but in particular provides a probe for nasoduodenal and / or nasojejunal nutrition, which due to the enlargement of the closure cap or probe tip (- bolus) easily - even in passive patients - and unaffected by gastric acid passes through the stomach and can be safely placed in the duodenum or jejunum. As a material for this further coating layer, one is used which is resistant to gastric acid or gastric juice, but in intestinal juice, i.e. in the intestinal milieu, is soluble. Examples of such materials are medically safe materials, such as anionic polymers made from methacrylic acid and methyl methacrylate, and mixtures thereof with other materials and with one another. Anionic polymers of methacrylic acid and methyl methacrylate, such as Eudragit S, Eudragit L and mixtures thereof (manufactured by Röhm Pharma), in particular Eudragit S, are preferred. Shellack and cellulose acetate phthalate are also suitable as coating material.
Die Dicke der Überzugsschicht ist nicht kritisch, jedoch sollte die Überzugsschicht so dick sein, daß die Verdickungsschicht vor dem Angriff der Magensäfte geschützt wird und andererseits nicht so dick sein, daß sie sich zu langsam auflöst und damit eine eventuelle Entfernung der Sonde aus dem Duodenum oder Jejunum behindert. Geeignete Dicken sind etwa 10-30 um, insbesondere ca. 25 µm. Der Überzug kann farblos, transparent, weiß oder andersfarbig pigmentiert sein; vorzugsweise ist er der Farbe des Sondenschlauches angepaßt.The thickness of the coating layer is not critical, but the coating layer should be so thick that the thickening layer is protected from the attack of the gastric juices and on the other hand not so thick that it dissolves too slowly and thus preventing any removal of the probe from the duodenum or jejunum. Suitable thicknesses are approximately 10-30 µm, in particular approximately 25 µm. The coating can be colorless, transparent, white or pigmented in a different color; it is preferably matched to the color of the probe tube.
Zur weiteren Erleichterung der Plazierung der Sonden, insbesondere der Nasoduodenal- und Nasojejunalsonden, weist die Verschlußkappe in ihrer Bohrung vorteilhafterweise einen Metallkopf oder Metallstopfen auf, der am distalen Ende des Sondenschlauches angeordnet ist oder es kann die Verschlußkappe als Metallkopf oder Metallstopfen ausgebildet sein. Ein solcher Metallkopf vergrößert das Gewicht der Sonde und versteift das distale Ende der Sonde, erleichtert somit das Legen bzw. Plazieren der Sonde erheblich, insbesondere bei passiven Patienten.To further facilitate the placement of the probes, particularly the nasoduodenal and nasojejunal probes, the closure cap advantageously has a metal head or metal plug in its bore, which is arranged at the distal end of the probe tube, or the closure cap can be designed as a metal head or metal plug. Such a metal head increases the weight of the probe and stiffens the distal end of the probe, thus considerably simplifying the placement or placement of the probe, particularly in the case of passive patients.
Geeignete Materialien für den Metallkopf bzw. den Metallstopfen sind für medizinische Zwecke geeignete, verträgliche Metalle, wie z.B. Edelstahl, Edelmetalle u.dgl. Insbesondere verwendet werden Metallköpfe bzw. Stopfen aus V4A- und V2A-Stahl.Suitable materials for the metal head or the metal plug are suitable, suitable metals for medical purposes, such as e.g. Stainless steel, precious metals and the like Metal heads or plugs made of V4A and V2A steel are used in particular.
Die Größe des Metallkopfes ist nicht kritisch und sollte im üblichen Größenbereich für Verschlußkappen liegen bzw. kann etwas kleiner sein, sollte jedoch so groß sein, daß der Metallkopf die gewünschte Funktion erfüllen kann. Geeigneterweise weist der Metallkopf etwa den gleichen Außendurchmesser auf wie die Sonde, während seine Länge von dem Gewicht bzw. der Halterung in der Sonde bestimmt wird. Desgleichen kann der Metallkopf jede geeignete Form aufweisen. Vorzugsweise ist er mittels eines Halses stopfenförmig in das distale Ende des Sondenschlauches eingefügt.The size of the metal head is not critical and should be in the usual size range for sealing caps or can be somewhat smaller, but should be large enough that the metal head can perform the desired function. The metal head suitably has approximately the same outer diameter as the probe, while its length is determined by the weight or the holder in the probe. Likewise, the metal head can have any suitable shape. It is preferably inserted in the shape of a plug into the distal end of the probe tube by means of a neck.
Über der als Metallkopf ausgebildeten Verschlußkappe oder über der einen Metallkopf beinhaltenden Verschlußkappe aus geeignetem, medizinisch verträglichem Material, wie Hartgelatine oder Kunststoff (z.B. Polyolefin, wie Polyethylen, oder Silocon), ist dann die Verdickungsschicht angeordnet, über welchem dann die Überzugsschicht aus magensaftresistentem, im Darmsaft löslichen Material, aufgebracht ist.The thickening layer is then arranged over the sealing cap designed as a metal head or over the sealing cap comprising a metal head made of suitable, medically compatible material such as hard gelatin or plastic (e.g. polyolefin, such as polyethylene or silocon), over which the coating layer of gastric juice-resistant, in Intestinal juice soluble material, is applied.
Der Sondenschlauch selbst besteht aus üblichem, für Sonden geeignetem Material, wie PVC, Silicon oder Polyurethan, vorzugsweise aus Silicon oder Polyurethan.The probe tube itself consists of a conventional material suitable for probes, such as PVC, silicone or polyurethane, preferably of silicone or polyurethane.
Zur temporären Versteifung des relativ weichen Sondenschlauches wird ein in üblicher Weise ausgestalteter Mandrin verwendet. Bei erfindungsgemäß vorhandenem Metallkopf am distalen Ende des Sondenschlauches mündet der Mandrin in einer Senkung oder Bohrung des Metallkopfes bzw. des Halsteiles dieses Metallkopfes, um ein Abknicken des Sondenschlauches an der Spitze zu verhindern. Vorzugsweise ist diese Bohrung im Halsteil des Metallkopfes vorgesehen.A stylet designed in the usual way is used to temporarily stiffen the relatively soft probe tube. If the metal head according to the invention is present at the distal end of the probe tube, the stylet opens into a depression or bore in the metal head or the neck part of this metal head in order to prevent the probe tube from kinking at the tip. This bore is preferably provided in the neck part of the metal head.
Der Sondenschlauch weist in üblicher Weise im Bereich des distalen Endes Öffnungen auf, die den Nahrungsaustritt gestatten. Die Zahl der Öffnungen ist nicht kritisch. Jedoch sollten soviele Öffnungen vorhanden sein, daß ein einwandfreier Nahrungsaustritt gestattet ist. Vorzugsweise sind zwei bis vier, insbesondere drei Öffnungen, vorhanden. Desgleichen sind vorzugsweise in üblicher Weise Markierungsstriche am Sondenschlauch vorgesehen, die beim Legen der Sonde zur Orientierung dienen.The probe tube has openings in the usual way in the region of the distal end, which allow food to escape. The number of openings is not critical. However, there should be so many openings that proper food leakage is permitted. There are preferably two to four, in particular three, openings. Likewise, marking lines are preferably provided in the usual way on the probe tube, which serve for orientation when the probe is placed.
Der Durchmesser und die Länge des Sondenschlauches hängen vom jeweiligen Verwendungszweck ab und liegen im üblicher Weise angewandten Bereich. Typischerweise sind nasogastrale Sonden 75 cm lang und weisen einen Innendurchmesser von 2-4 mm auf; Nasoduodenal-oder Nasojejunalsonden weisen eine Länge von vorzugsweise 1,25 m, einen Innendurchmesser von 1,2-1,6 mm und einen Außendurchmesser von 2-2,4 mm auf.The diameter and the length of the probe tube depend on the intended use and are in the usual range. Typically, nasogastric probes are 75 cm long and have an inner diameter of 2-4 mm; Nasoduodenal or nasojejunal probes have a length of preferably 1.25 m, an inner diameter of 1.2-1.6 mm and an outer diameter of 2-2.4 mm.
Am proximalen Ende des Sondenschlauches sind übliche Anschlußeinrichtungen, die einmal zur Befestigung des Mandrins bzw. später nach Plazierung der Sonde in üblicher Weise zur Aufnahme bzw. zum Anschluß von Verbindungsleitungen bzw. Schläuchen dienen, über die die Sonde mit der Ernährungspumpe bzw. weiteren Zuführungsleitungen für die Nahrung verbunden ist, angebracht. Diese Anschlußeinrichtungen können beispielsweise in Form eines Konnektorteils mit Lueranschluß, eines Steckanschlußes oder dgl. vorliegen. Vorzugsweise verwendet wird ein Steckanschluß oder ein Konnektorteil mit Luerkonus, insbesondere ein Konnektorteil mit Luerkonus.At the proximal end of the probe tube are customary connection devices, which are used once for attaching the stylet or later after placing the probe in the usual manner for receiving or connecting connecting lines or hoses, via which the probe with the nutritional pump or other supply lines for the food is attached, attached. These connection devices can be present, for example, in the form of a connector part with a Luer connection, a plug connection or the like. A plug-in connection or a connector part with a Luer cone is preferably used, in particular a connector part with a Luer cone.
Die Herstellung der erfindungsgemäßen Sonde erfolgt in üblicher Weise. Der Metallkopf wird vorzugsweise über einen halsförmig ausgebildeten Teil des Metallstückes stopfenförmig in das distale Ende des Sondenschlauches eingesteckt. Anschließend kann dann beispielsweise das so mit dem Metallkopf ausgestattete distale Ende des Sondenschlauches mit der Verdickungsschicht versehen werden, indem man das mit dem Metallkopf versehene Ende des distalen Sondenschlauches in eine erwärmte Gelatinemasse eintaucht und dann herauszieht, um es mit einem weiteren Überzug aus magensaftresistentem Material zu überziehen, was in üblicher Weise, gegebenenfalls durch Aufsprühen, erfolgen kann. Das Eintauchen des distalen Endes in die erwärmte Gelatinemasse geschieht vorzugsweise durch schräges Eintauchen, d.h. Eintauchen unter einem Winkel von weniger als 90°.The probe according to the invention is produced in the usual way. The metal head is preferably inserted into the distal end of the probe tube in a plug-like manner via a neck-shaped part of the metal piece. Then, for example, the distal end of the probe tube equipped with the metal head can be provided with the thickening layer by immersing the end of the distal probe tube provided with the metal head in a heated gelatin mass and then pulling it out in order to cover it with a further coating of gastric juice-resistant material coat what can be done in the usual way, if necessary by spraying. The immersion of the distal end in the heated gelatin mass is preferably done by oblique immersion, i.e. Immerse at an angle of less than 90 °.
Nachfolgend wird die vorliegende Erfindung weiter unter Bezugnahme auf die Zeichnungen erläutert.In the following, the present invention is further explained with reference to the drawings.
Es zeigen:
- Fig. 1 eine schematische Seitenansicht einer bevorzugten Ausführuhgsform einer erfindungsgemäßen Sonde.
- Fig. 2 einen vergrößerten Längsschnitt durch das distale Ende der Sonde gemäß Fig. 1 entlang der Linie I-I.
- Fig. 3 einen Querschnitt durch das distale Ende der Sonde gemäß Fig. 1 bzw. 2 entlang der Linie 11-11.
- Fig. 1 is a schematic side view of a preferred embodiment of a probe according to the invention.
- FIG. 2 shows an enlarged longitudinal section through the distal end of the probe according to FIG. 1 along the line II.
- 3 shows a cross section through the distal end of the probe according to FIGS. 1 and 2 along the line 11-11.
In Fig. 1 ist mit 1 die Sondenspitze oder der Bolus am distalen Ende der erfindungsgemäßen Sonde und mit 2 der Sondenschlauch bezeichnet. Am proximalen Ende der Sonde befindet sich eine übliche Anschluß- oder Verbindungseinrichtung 3 für den Mandrin 6 bzw. andere Zuführungs- oder Verbindungsleitungen, die, wie dargestellt, in Gestalt eines Lueranschlusses vorliegen kann oder aber jede andere geeignete Form haben kann, z.B. in Form eines Steckanschlusses vorliegen kann. In dieser Anschlußeinrichtung ist die entsprechende Anschluß- bzw. Verbindungseinrichtung 4 des Mandrins 6 eingefügt, die zur Erleichterung der Handhabung vorzugsweise sogen. Griffleisten 5 trägt.In Fig. 1, the probe tip or the bolus at the distal end of the probe according to the invention is denoted by 1 and by 2 the probe tube. At the proximal end of the probe there is a customary connection or
Am distalen Ende des Sondenschlauches ist stopfenförmig der Metallkopf 7 im Sondenschlauch 2 angeordnet. Über dem Metallkopf 7 befindet sich eine Verdickungsschicht 8 aus einem vom Körper des Patienten resorbierbaren Material, vorzugsweise Gelatine, auf welcher vorzugsweise eine Überzugsschicht 9 aus einem magensaftresistenten, darmsaftlöslichen Material (vorzugsweise Eudragit S) aufgebracht ist. Diese Verdickungsschicht 8 weist vorteilhafterweise die vorstehend erwähnten Abmessungen auf.At the distal end of the probe tube, the
Im Bereich des distalen Endes sind im Sondenschlauch eine oder mehrere Öffnungen 10 zum Austritt der Nahrung vorgesehen.In the area of the distal end, one or
Die Fig. 2 veranschaulicht einen vergrößerten Längsschnitt durch den Bereich des distalen Endes und des Bolus der erfindungsgemäßen Sonde gemäß Fig. 1, wobei die Bezugszahlen den in Fig. 1 verwendeten entsprechen. Deutlich sichtbar in der vergrößerten Darstellung ist die Sondenspitze oder der Sondenbolus 1 mit dem auf dem distalen Ende des Sondenschlauches 2 aufgesetzten Metallkopf 7, der mit dem Halsteil 7a stopfenförmig in das Schlauchende eingefügt ist. Der Halsteil 7a des Metallkopfes 7 weist eine Bohrung 11 zur Aufnahme des distalen Endes des Mandrins 6 auf. Dieser Metallkopf kann auch eine andere geeignete Form besitzen, z.B. kann er birnenförmig gestaltet sein, oder auch im wesentlichen zylinderförmig vorliegen.FIG. 2 illustrates an enlarged longitudinal section through the region of the distal end and the bolus of the probe according to the invention according to FIG. 1, the reference numbers corresponding to those used in FIG. 1. The probe tip or the probe bolus 1 with the
Wie aus Fig. 2 ersichtlich, ist über das distale Ende des Sondenschlauches 2 und den Metallkopf 7 zunächst die Verdickungsschicht 8 und auf diesem die Überzugsschicht 9 aus magensaftresistentem, darmsaftlöslichem Material aufgebracht. Die Öffnungen 10 im Schlauch 2 dienen zum Nahrungsaustritt.As can be seen from FIG. 2, the thickening
Der in Fig. 3 dargestellte Querschnitt entlang der Linie 11-11 gemäß Fig. 1 oder 2 zeigt, wie das distale Ende des Sondenschlauches 2 den Halsteil 7a des Metallkopfes 7 umgibt und selbst von der Verdickungsschicht 8 und der Überzugsschicht 9 aus dem magensaftresistenten, darmsaftlöslichen Material umgeben ist.The cross section shown in FIG. 3 along the line 11-11 according to FIG. 1 or 2 shows how the distal end of the
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT85103028T ATE47308T1 (en) | 1984-03-16 | 1985-03-15 | MEDICAL PROBE. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3409663A DE3409663C2 (en) | 1984-03-16 | 1984-03-16 | Medical probe |
DE3409663 | 1984-03-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0155009A2 EP0155009A2 (en) | 1985-09-18 |
EP0155009A3 EP0155009A3 (en) | 1986-07-23 |
EP0155009B1 true EP0155009B1 (en) | 1989-10-18 |
Family
ID=6230695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP85103028A Expired EP0155009B1 (en) | 1984-03-16 | 1985-03-15 | Medical tube |
Country Status (7)
Country | Link |
---|---|
US (1) | US4692152A (en) |
EP (1) | EP0155009B1 (en) |
AT (1) | ATE47308T1 (en) |
AU (1) | AU577839B2 (en) |
DE (2) | DE3409663C2 (en) |
ES (1) | ES296032Y (en) |
PT (1) | PT80114B (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4846784A (en) * | 1987-07-01 | 1989-07-11 | C. R. Bard, Inc. | Manually adjustable sphincteric system |
DD274130A3 (en) * | 1987-11-02 | 1989-12-13 | Kreiskrankenhaus Grimma | GUIDE PART FOR DUTIES |
US4947842A (en) * | 1988-09-22 | 1990-08-14 | Medical Engineering And Development Institute, Inc. | Method and apparatus for treating tissue with first and second modalities |
US5017193A (en) * | 1988-09-26 | 1991-05-21 | Tri-State Hospital Supply Corp. | Infant feeding device |
DE58903472D1 (en) * | 1989-08-09 | 1993-03-18 | Siemens Ag | IMPLANTABLE INJECTION BODY. |
US5049138A (en) * | 1989-11-13 | 1991-09-17 | Boston Scientific Corporation | Catheter with dissolvable tip |
US5971954A (en) * | 1990-01-10 | 1999-10-26 | Rochester Medical Corporation | Method of making catheter |
DE4000570A1 (en) * | 1990-01-10 | 1991-07-11 | Pfrimmer Viggo Gmbh Co Kg | PROBE TO INSERT INTO A BODY CAVE |
US5261896A (en) * | 1990-01-10 | 1993-11-16 | Rochester Medical Corporation | Sustained release bactericidal cannula |
US5098379A (en) * | 1990-01-10 | 1992-03-24 | Rochester Medical Corporation | Catheter having lubricated outer sleeve and methods for making and using same |
US5269770A (en) * | 1990-01-10 | 1993-12-14 | Rochester Medical Corporation | Microcidal agent releasing catheter with balloon |
US6626888B1 (en) | 1990-01-10 | 2003-09-30 | Rochester Medical Corporation | Method of shaping structures with an overcoat layer including female urinary catheter |
US5360402A (en) * | 1990-01-10 | 1994-11-01 | Rochester Medical Corporation | Hand-actuated retention catheter |
US5670111A (en) * | 1990-01-10 | 1997-09-23 | Rochester Medical Corporation | Method of shaping structures with an overcoat layer including female urinary catheter |
US5152756A (en) * | 1990-01-24 | 1992-10-06 | Corpak, Inc. | Distal gripping tip for enteral feeding tube |
US5037387A (en) * | 1990-01-24 | 1991-08-06 | Corpak, Inc. | Method of positioning an enteral feeding tube within a patient's body |
US5242429A (en) * | 1992-05-14 | 1993-09-07 | Nwaneri Ngozika J | Enteral feeding tube with guide wire |
US5401257A (en) * | 1993-04-27 | 1995-03-28 | Boston Scientific Corporation | Ureteral stents, drainage tubes and the like |
AT402683B (en) * | 1995-05-16 | 1997-07-25 | Hafslund Nycomed Pharma | DEVICE FOR ENDOSCOPIC OR LAPAROSCOPIC APPLICATION OF SURGICAL MATERIAL |
US5795288A (en) * | 1996-08-08 | 1998-08-18 | Cohen; Kenneth L. | Apparatus with valve for treating incontinence |
US5792042A (en) * | 1996-08-08 | 1998-08-11 | Cohen; Kenneth L. | Apparatus for treating incontinence in females |
US5902285A (en) * | 1997-01-27 | 1999-05-11 | Novartis Nutrition Ag | Jejunal feeding tube |
JP3578446B2 (en) * | 1999-04-02 | 2004-10-20 | カネボウ合繊株式会社 | Thermoplastic resin composition |
US20030225393A1 (en) * | 2002-05-31 | 2003-12-04 | Kimberly-Clark Worldwide, Inc. | Low profile transpyloric jejunostomy system and method to enable |
US20030225392A1 (en) * | 2002-05-31 | 2003-12-04 | Kimberly-Clark Worldwide, Inc. | Low profile transpyloric jejunostomy system and method to enable |
US20030225369A1 (en) * | 2002-05-31 | 2003-12-04 | Kimberly-Clark Worldwide, Inc. | Low profile transpyloric jejunostomy system |
US7976518B2 (en) | 2005-01-13 | 2011-07-12 | Corpak Medsystems, Inc. | Tubing assembly and signal generator placement control device and method for use with catheter guidance systems |
US7785291B2 (en) * | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US8864730B2 (en) | 2005-04-12 | 2014-10-21 | Rochester Medical Corporation | Silicone rubber male external catheter with absorbent and adhesive |
US9265865B2 (en) | 2006-06-30 | 2016-02-23 | Boston Scientific Scimed, Inc. | Stent having time-release indicator |
DE102008015961A1 (en) * | 2008-03-20 | 2009-09-24 | Gelita Ag | Use of gelatin particles in powder coating process |
US9707375B2 (en) | 2011-03-14 | 2017-07-18 | Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. | Catheter grip and method |
US9028441B2 (en) | 2011-09-08 | 2015-05-12 | Corpak Medsystems, Inc. | Apparatus and method used with guidance system for feeding and suctioning |
EP2570107A1 (en) * | 2011-09-15 | 2013-03-20 | Ludwig-Maximilians-Universität München | Self-applicable gastric tube assembly |
US10507127B2 (en) | 2012-06-07 | 2019-12-17 | Epitomee Medical Ltd. | Expandable device |
US9872969B2 (en) | 2012-11-20 | 2018-01-23 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Catheter in bag without additional packaging |
US10092728B2 (en) | 2012-11-20 | 2018-10-09 | Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. | Sheath for securing urinary catheter |
EP3091962B1 (en) | 2013-12-05 | 2022-06-08 | Epitomee Medical Ltd. | Retentive devices and systems for in-situ release of pharmaceutical active agents |
CN106659820A (en) | 2014-08-26 | 2017-05-10 | C·R·巴德股份有限公司 | Urinary catheter |
MX2020002752A (en) | 2017-09-19 | 2020-07-20 | Bard Inc C R | Urinary catheter bridging device, systems and methods thereof. |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2499858A1 (en) * | 1981-02-18 | 1982-08-20 | Ruesch Gmbh & Co Kg Willy | PROBE FOR INTESTINAL TREATMENT |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2603217A (en) * | 1952-07-15 | mcshirley | ||
US2118631A (en) * | 1935-04-03 | 1938-05-24 | Wappler Frederick Charles | Catheter stylet |
US2489067A (en) * | 1944-05-01 | 1949-11-22 | Andrew E Carlsen | Intubator apparatus for intestinal intubation |
US2508690A (en) * | 1948-07-13 | 1950-05-23 | Schmerl Egon Fritz | Gastrointestinal tube |
US2773502A (en) * | 1953-12-21 | 1956-12-11 | Arthur L Kaslow | Device for treating alimentary tract |
US3155097A (en) * | 1962-07-17 | 1964-11-03 | Barron James | Feeding and suction tubes |
US3395710A (en) * | 1965-06-14 | 1968-08-06 | Robert A. Stratton | Gastro-intestinal tube with inflatable weight releasing means |
US3528429A (en) * | 1968-10-21 | 1970-09-15 | Charles B Beal | Method and device for orally admitting an elongated flexible element in the alimentary canal |
US3736939A (en) * | 1972-01-07 | 1973-06-05 | Kendall & Co | Balloon catheter with soluble tip |
US3780740A (en) * | 1972-11-01 | 1973-12-25 | J Rhea | Intubation device and method of advancing a tube past the pylorus |
US3938529A (en) * | 1974-07-22 | 1976-02-17 | Gibbons Robert P | Indwelling ureteral catheter |
DE2810326C2 (en) * | 1978-03-10 | 1980-05-14 | Wolf-Ruediger Dr. Med. 3551 Marbach Gercke-Kaupert | Probe for enteral feeding of living things |
DE2824893C2 (en) * | 1978-06-07 | 1980-04-24 | Willy Ruesch Gmbh & Co Kg, 7053 Kernen | Enteral treatment probe |
US4257421A (en) * | 1979-01-10 | 1981-03-24 | Health Development Corporation | Gastro-intestinal tube guide and stiffener |
DE2914609A1 (en) * | 1979-04-11 | 1980-10-23 | Lauterjung F G | PROBE |
US4431426A (en) * | 1979-08-20 | 1984-02-14 | Groshong Leroy E | Methods and apparatus for intravenous therapy and hyperalimentation |
US4306563A (en) * | 1979-11-28 | 1981-12-22 | Firma Pfrimmer & Co. Pharmazeutische Werke Erlangen Gmbh | Catheter for introduction into body cavities |
US4390017A (en) * | 1981-08-07 | 1983-06-28 | Harrison Eugene O | Enteral feeding system |
US4410320A (en) * | 1981-08-28 | 1983-10-18 | Ethox Corp. | Weighted enteric feeding tube |
US4515593A (en) * | 1981-12-31 | 1985-05-07 | C. R. Bard, Inc. | Medical tubing having exterior hydrophilic coating for microbiocide absorption therein and method for using same |
US4516970A (en) * | 1982-09-13 | 1985-05-14 | Kaufman Jack W | Medical device |
US4490143A (en) * | 1982-09-24 | 1984-12-25 | Viridian, Inc. | Feeding tube assembly |
FR2546069B1 (en) * | 1983-05-20 | 1985-08-30 | Centre Nat Rech Scient | INFLATABLE AND RELEASABLE BALLOON CATHETER |
-
1984
- 1984-03-16 DE DE3409663A patent/DE3409663C2/en not_active Expired
-
1985
- 1985-03-12 AU AU39768/85A patent/AU577839B2/en not_active Ceased
- 1985-03-15 PT PT80114A patent/PT80114B/en not_active IP Right Cessation
- 1985-03-15 EP EP85103028A patent/EP0155009B1/en not_active Expired
- 1985-03-15 DE DE8585103028T patent/DE3573721D1/en not_active Expired
- 1985-03-15 US US06/712,265 patent/US4692152A/en not_active Expired - Fee Related
- 1985-03-15 ES ES1985296032U patent/ES296032Y/en not_active Expired
- 1985-03-15 AT AT85103028T patent/ATE47308T1/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2499858A1 (en) * | 1981-02-18 | 1982-08-20 | Ruesch Gmbh & Co Kg Willy | PROBE FOR INTESTINAL TREATMENT |
Also Published As
Publication number | Publication date |
---|---|
ES296032Y (en) | 1989-02-01 |
ES296032U (en) | 1988-05-16 |
ATE47308T1 (en) | 1989-11-15 |
AU577839B2 (en) | 1988-10-06 |
EP0155009A3 (en) | 1986-07-23 |
EP0155009A2 (en) | 1985-09-18 |
DE3573721D1 (en) | 1989-11-23 |
DE3409663A1 (en) | 1985-09-19 |
PT80114B (en) | 1986-10-28 |
DE3409663C2 (en) | 1987-02-19 |
AU3976885A (en) | 1985-09-19 |
PT80114A (en) | 1985-04-01 |
US4692152A (en) | 1987-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0155009B1 (en) | Medical tube | |
DE69431530T2 (en) | BENDING HOLDING FLANGE FOR A NUTRITION PROBE | |
US2773502A (en) | Device for treating alimentary tract | |
DE3879954T2 (en) | PROTECTIVE SLEEVES FOR CATHETERS. | |
DE3506653C2 (en) | Medical device | |
DE2941463C2 (en) | ||
DE29801204U1 (en) | Jejunal feeding tube | |
DE69931357T2 (en) | DEVICE FOR ANCHORING AND POSITIONING AN ENDOSCOPE | |
DE60210141T2 (en) | ACCESS NEEDLE FOR THE PERCUTANEOUS ENDOSCOPIC PLACEMENT OF A GASTRO / JEJEUNAL PROBE | |
DE69227598T2 (en) | HEART PACER PROBE WITH A REPLACEABLE SENSOR | |
DE1766363A1 (en) | Nasogastric tube | |
EP0238952A2 (en) | Catheter for percutaneous gastrotomy | |
DE20211804U1 (en) | Infection protection cover or catheter set and gastrostomy catheter for use in a gastrostomy procedure | |
DE102006021016A1 (en) | Chemically activatable capsule for continuity check and treatment of intestinal tract, comprises interior covering with opposite discharge openings and with a filling from granulates, powder, gel or liquid, and outer covering | |
DE202018006434U1 (en) | System and catheter for pituitary and brain implantation | |
DE29801202U1 (en) | Post-pyloric feeding tubes | |
DE69720400T2 (en) | Gastrostomy tube for enteral nutrition | |
DE202017101527U1 (en) | Self-scoring gastrointestinal nasal catheter | |
DE69629243T2 (en) | catheter | |
DE2205314C3 (en) | Device for the infusion of liquids into the bones | |
DE3820213C2 (en) | Guide probe for small intestinal splinting | |
EP0437248B1 (en) | Catheter for introducing into a body cavity | |
DE10154864A1 (en) | Stylet for a catheter, length meter for determining the stoma length and set for enteral nutrition | |
AT406121B (en) | Anaesthesiology needle | |
DE1566300C (en) | Nasal stomach probe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
17P | Request for examination filed |
Effective date: 19861127 |
|
17Q | First examination report despatched |
Effective date: 19880322 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
REF | Corresponds to: |
Ref document number: 47308 Country of ref document: AT Date of ref document: 19891115 Kind code of ref document: T |
|
REF | Corresponds to: |
Ref document number: 3573721 Country of ref document: DE Date of ref document: 19891123 |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) | ||
ET | Fr: translation filed | ||
ITF | It: translation for a ep patent filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
ITTA | It: last paid annual fee | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19920226 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19920316 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19920320 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19920324 Year of fee payment: 8 Ref country code: AT Payment date: 19920324 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19920331 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 19920403 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19920421 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19920513 Year of fee payment: 8 |
|
EPTA | Lu: last paid annual fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19930315 Ref country code: GB Effective date: 19930315 Ref country code: AT Effective date: 19930315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19930316 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Effective date: 19930331 Ref country code: CH Effective date: 19930331 Ref country code: BE Effective date: 19930331 |
|
BERE | Be: lapsed |
Owner name: FRESENIUS A.G. Effective date: 19930331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19931001 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 19930315 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Effective date: 19931130 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19931201 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
EUG | Se: european patent has lapsed |
Ref document number: 85103028.8 Effective date: 19931008 |